CVRx Inc (CVRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses [Yahoo! Finance]
CVRx, Inc. (CVRX)
Company Research
Source: Yahoo! Finance
4 min read In This Article CVRX Total Revenue: $15.3 million, a 36% increase over Q4 2023. US Heart Failure Revenue: $14.3 million, a 41% increase over Q4 2023. Gross Profit: $12.8 million, up $3.2 million from Q4 2023. Gross Margin: 83%, compared to 85% in Q4 2023. Research and Development Expenses: $2.8 million, a 25% increase from Q4 2023. SG&A Expenses: $20.2 million, a 19% increase from Q4 2023. Net Loss: $10.7 million or $0.43 per share, compared to $9.2 million or $0.44 per share in Q4 2023. Cash and Cash Equivalents: $105.9 million as of December 31, 2024. Active Implanting Centers: 223 centers, up from 178 at the end of 2023. Sales Territories in the US: 48 territories, up from 38 at the end of 2023. Revenue Guidance for 2025: Expected between $63 million and $65 million. Gross Margin Guidance for 2025: Expected between 83% and 84%. Operating Expenses Guidance for 2025: Expected between $100 million and $104 million. Warning! GuruFocus has det
Show less
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- CVRx to Participate at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- With 41% stake, CVRx, Inc. (NASDAQ:CVRX) seems to have captured institutional investors' interest [Yahoo! Finance]Yahoo! Finance
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $9.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
- CVRx Inc (CVRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions [Yahoo! Finance]Yahoo! Finance
CVRX
Earnings
- 11/5/25 - Beat
CVRX
Sec Filings
- 12/1/25 - Form 4
- 11/25/25 - Form 4
- 11/17/25 - Form DEL
- CVRX's page on the SEC website